Where Will Salesforce Stock Be in 5 Years?
Salesforce (NYSE: CRM) just turned in a quarter that, on…
Buy
65
TGTX Quote, Financials, Valuation and Earnings
Last price:
$35.08
Seasonality move
:
-6.22%
Day range:
$34.41 - $35.60
52-week range:
$15.16 - $46.48
Dividend yield:
0%
P/E ratio:
146.17x
P/S ratio:
14.60x
P/B ratio:
23.47x
Volume:
1.8M
Avg. volume:
2.6M
1-year change:
107.7%
Market cap:
$5.6B
Revenue:
$329M
EPS (TTM):
$0.24
Earnings Data
Next earnings date for TGTX
Aug 06
2025
Most recent earnings per share
$0.03
Missed by $0.14
(May 5/2025)
Consensus Estimate
$0.17
(May 5/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
TGTX Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 08/06/2025 | Q2 | $147.8M | -- | -- | $0.30 | -- |
| 05/05/2025 | Q1 | $117.9M | $120.9M | $0.03 | $0.17 | -$0.14 |
| 03/03/2025 | Q4 | $100.7M | $108.2M | $0.15 | $0.20 | -$0.05 |
| 11/04/2024 | Q3 | $81.7M | $83.9M | $0.02 | $0.03 | -$0.01 |
| 08/06/2024 | Q2 | $65.9M | $73.5M | $0.04 | -$0.04 | $0.08 |
| 05/01/2024 | Q1 | $54.6M | $63.5M | -$0.07 | -$0.05 | -$0.03 |
| 02/28/2024 | Q4 | $40.1M | $44M | -$0.10 | -$0.11 | $0.01 |
| 11/01/2023 | Q3 | -- | -- | $0.73 | $0.10 | $0.63 |
| 08/01/2023 | Q2 | -- | -- | -$0.34 | -$0.25 | -$0.09 |
| 05/01/2023 | Q1 | -- | -- | -$0.28 | -$0.34 | $0.06 |
| 02/28/2023 | Q4 | -- | -- | -$0.39 | -$0.26 | -$0.13 |
| 11/10/2022 | Q3 | -- | -- | -$0.26 | -$0.38 | $0.12 |
| 08/08/2022 | Q2 | -- | -- | -$0.30 | -$0.57 | $0.27 |
| 05/10/2022 | Q1 | -- | -- | -$0.51 | -$0.63 | $0.12 |
| 03/01/2022 | Q4 | -- | -- | -$0.70 | -$0.68 | -$0.02 |
| 11/04/2021 | Q3 | -- | -- | -$0.65 | -$0.57 | -$0.08 |
| 08/02/2021 | Q2 | -- | -- | -$0.59 | -$0.50 | -$0.09 |
| 05/10/2021 | Q1 | -- | -- | -$0.69 | -$0.50 | -$0.19 |
| 03/02/2021 | Q4 | -- | -- | -$0.71 | -$0.61 | -$0.10 |
| 11/09/2020 | Q3 | -- | -- | -$0.73 | -$0.44 | -$0.29 |
| 08/10/2020 | Q2 | -- | -- | -$0.47 | -$0.33 | -$0.14 |
| 05/11/2020 | Q1 | -- | -- | -$0.48 | -$0.38 | -$0.11 |
| 03/03/2020 | Q4 | -- | -- | -$0.44 | -$0.50 | $0.06 |
| 11/12/2019 | Q3 | -- | -- | -$0.69 | -$0.36 | -$0.34 |
| 08/09/2019 | Q2 | -- | -- | -$0.42 | -$0.42 | -- |
| 05/10/2019 | Q1 | -- | -- | -$0.43 | -$0.44 | $0.01 |
| 03/01/2019 | Q4 | -- | -- | -$0.69 | -$0.43 | -$0.27 |
| 11/09/2018 | Q3 | -- | -- | -$0.43 | -$0.50 | $0.07 |
| 08/07/2018 | Q2 | -- | -- | -$0.59 | -- | -- |
| 05/08/2018 | Q1 | -- | -- | -$0.59 | -- | -- |
| 03/08/2018 | Q4 | -- | -- | -$0.46 | -- | -- |
| 11/08/2017 | Q3 | -- | -- | -$0.48 | -- | -- |
| 08/09/2017 | Q2 | -- | -- | -$0.45 | -- | -- |
| 05/05/2017 | Q1 | -- | -- | -$0.52 | -- | -- |
| 03/10/2017 | Q4 | -- | -- | -$0.48 | -- | -- |
| 11/07/2016 | Q3 | -- | -- | -$0.50 | -- | -- |
| 08/08/2016 | Q2 | -- | -- | -$0.33 | -- | -- |
| 05/10/2016 | Q1 | -- | -- | -$0.28 | -- | -- |
| 03/07/2016 | Q4 | -- | -- | -$0.37 | -- | -- |
| 11/09/2015 | Q3 | -- | -- | -$0.28 | -- | -- |
| 08/10/2015 | Q2 | -- | -- | -$0.38 | -- | -- |
TG Therapeutics Earnings Questions
-
How Much did TG Therapeutics Generate in Revenue Last Quarter?
TG Therapeutics reported $120.9M worth of top line sales in its most recent quarter.
-
Did TG Therapeutics Beat Earnings Last Quarter?
TG Therapeutics announced earnings per share of $0.03 which represents a miss of analyst forecast a $0.17 per share.
-
Is TG Therapeutics Profitable?
TG Therapeutics reported $105.3M that represents $0.65 per share over the last quarter.
-
What is the Analyst Consensus for TG Therapeutics EPS Next Year?
TG Therapeutics's earnings are forecast to grow from $0.15 per share to $0.19 per share next year representing an increase of 534.65%.
-
When is TG Therapeutics's Earnings Date?
TG Therapeutics's next earnings date is August 6, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
2 Ultra Safe Dividend Stocks to Buy Now
Historically, blue-chip dividend stocks have been good choices for periods…
Where Will Asana Stock Be in 5 Years?
Asana stock hasn’t given many investors on Wall Street any…
Stock Ideas
Buy
67
Is MSFT Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 39x
Buy
65
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 46x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Alerts
Sell
31
REGN alert for May 31
Regeneron Pharmaceuticals [REGN] is down 19.04% over the past day.
Buy
55
RGC alert for May 31
Regencell Bioscience Holdings [RGC] is up 16.13% over the past day.
Sell
42
AMBA alert for May 31
Ambarella [AMBA] is down 15.13% over the past day.
